AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells

Life Sciences

Volumn 131, Issue , 2015, Pages 23-29

  Lv, Qiong ^a   Zhen, Qianna ^a   Liu, Lulu ^a   Gao, Rufei ^a   Yang, Shumin ^a   Zhou, Huang ^a   Goswami, Richa ^a   Li, Qifu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

AMPK; Lipid accumulation; Metformin; mTOR; SREBP 1; TNF

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; FAS ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; METFORMIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; MTOR PROTEIN, HUMAN; RIBONUCLEOTIDE; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL STRESS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE EXPRESSION; HEPATOMA CELL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; INFLAMMATION; LIPID STORAGE; NONALCOHOLIC FATTY LIVER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; LIPID METABOLISM; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; CARCINOMA, HEPATOCELLULAR; HEP G2 CELLS; HUMANS; LIPID METABOLISM; LIVER NEOPLASMS; METFORMIN; PHOSPHORYLATION; RIBONUCLEOTIDES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928560607     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.03.003     Document Type: Article

References (29)

1. V. Bieghs, and C. Trautwein The innate immune response during liver inflammation and metabolic disease Trends Immunol. 34 9 2013 446 452
2. E. Bugianesi, E. Gentilcore, R. Manini, S. Natale, E. Vanni, N. Villanova, E. David, M. Rizzetto, and G. Marchesini A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease Am. J. Gastroenterol. 100 5 2005 1082 1090
3. D. Carling AMP-activated protein kinase: balancing the scales Biochimie 87 1 2005 87 91
4. Y. Chen, Y. Chen, L. Zhao, Y. Chen, M. Mei, Q. Li, A. Huang, Z. Varghese, J.F. Moorhead, and X.Z. Ruan Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export J. Gastroenterol. Hepatol. 27 5 2012 974 984
5. D.E. Cintra, J.R. Pauli, E.P. Araujo, J.C. Moraes, C.T. de Souza, M. Milanski, J. Morari, A. Gambero, M.J. Saad, and L.A. Velloso Interleukin-10 is a protective factor against diet-induced insulin resistance in liver J. Hepatol. 48 4 2008 628 637
6. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 4 1998 842 845
7. B.M. De Taeye, T. Novitskaya, O.P. McGuinness, L. Gleaves, M. Medda, J.W. Covington, and D.E. Vaughan Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity Am. J. Physiol. Endocrinol. Metab. 293 3 2007 E713 E725
8. D. Detaille, B. Guigas, C. Chauvin, C. Batandier, E. Fontaine, N. Wiernsperger, and X. Leverve Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process Diabetes 54 7 2005 2179 2187
9. V.W. Dolinsky, A.Y. Chan, I. Robillard Frayne, P.E. Light, C. Des Rosiers, and J.R. Dyck Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1 Circulation 119 12 2009 1643 1652
10. K. Duvel, J.L. Yecies, S. Menon, P. Raman, A.I. Lipovsky, A.L. Souza, E. Triantafellow, Q. Ma, R. Gorski, S. Cleaver, M.G. Vander Heiden, J.P. MacKeigan, P.M. Finan, C.B. Clish, L.O. Murphy, and B.D. Manning Activation of a metabolic gene regulatory network downstream of mTOR complex 1 Mol. Cell 39 2 2010 171 183
11. J.W. Haukeland, J.K. Damas, Z. Konopski, E.M. Loberg, T. Haaland, I. Goverud, P.A. Torjesen, K. Birkeland, K. Bjoro, and P. Aukrust Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 J. Hepatol. 44 6 2006 1167 1174
12. T. Jiang, Z. Wang, G. Proctor, S. Moskowitz, S.E. Liebman, T. Rogers, M.S. Lucia, J. Li, and M. Levi Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway J. Biol. Chem. 280 37 2005 32317 32325
13. E.J. Jung, S.W. Kwon, B.H. Jung, S.H. Oh, and B.H. Lee Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver J. Lipid Res. 52 9 2011 1617 1625
14. K. Kawanaka, L.A. Nolte, D.H. Han, P.A. Hansen, and J.O. Holloszy Mechanisms underlying impaired GLUT- 4 translocation in glycogen-supercompensated muscles of exercised rats Am. J. Physiol. Endocrinol. Metab. 279 6 2000 E1311 E1318
15. J.-E. Kim, Y.-W. Kim, I.K. Lee, J.-Y. Kim, Y.J. Kang, and S.-Y. Park AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression J. Pharmacol. Sci. 106 3 2008 394 403
16. C.J. Liu Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese J. Gastroenterol. Hepatol. 27 10 2012 1555 1560
17. M. Mei, L. Zhao, Q. Li, Y. Chen, A. Huang, Z. Varghese, J.F. Moorhead, S. Zhang, S.H. Powis, Q. Li, and X.Z. Ruan Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice Lipids Health Dis. 10 2011 110
18. S. Nair, A.M. Diehl, M. Wiseman, G.H. Farr Jr., and R.P. Perrillo Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial Aliment. Pharmacol. Ther. 20 1 2004 23 28
19. S.H. Park, B.I. Kim, J.W. Yun, J.W. Kim, D.I. Park, Y.K. Cho, I.K. Sung, C.Y. Park, C.I. Sohn, W.K. Jeon, H. Kim, E.J. Rhee, W.Y. Lee, and S.W. Kim Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men J. Gastroenterol. Hepatol. 19 6 2004 694 698
20. R. Rafaeloff-Phail, L. Ding, L. Conner, W.K. Yeh, D. McClure, H. Guo, K. Emerson, and H. Brooks Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH J. Biol. Chem. 279 51 2004 52934 52939
21. J.W. Scott, S.A. Hawley, K.A. Green, M. Anis, G. Stewart, G.A. Scullion, D.G. Norman, and D.G. Hardie CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations J. Clin. Invest. 113 2 2004 274 284
22. G.R. Steinberg, B.J. Michell, B.J. van Denderen, M.J. Watt, A.L. Carey, B.C. Fam, S. Andrikopoulos, J. Proietto, C.Z. Gorgun, D. Carling, G.S. Hotamisligil, M.A. Febbraio, T.W. Kay, and B.E. Kemp Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling Cell Metab. 4 6 2006 465 474
23. F. Tacke, T. Luedde, and C. Trautwein Inflammatory pathways in liver homeostasis and liver injury Clin. Rev. Allergy Immunol 36 1 2009 4 12
24. E.B. Taylor, W.J. Ellingson, J.D. Lamb, D.G. Chesser, and W.W. Winder Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25 Am. J. Physiol. Endocrinol. Metab. 288 6 2005 E1055 E1061
25. S.J. Wang, Q.Y. Bo, X.H. Zhao, X. Yang, Z.F. Chi, and X.W. Liu Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling Brain Res. 1492 2013 122 129
26. S.L. Woo, H. Xu, H. Li, Y. Zhao, X. Hu, J. Zhao, X. Guo, T. Guo, R. Botchlett, T. Qi, Y. Pei, J. Zheng, Y. Xu, X. An, L. Chen, Q. Li, X. Xiao, Y. Huo, and C. Wu Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity PLoS One 9 3 2014 e91111
27. S. Zhong, L. Zhao, Q. Li, P. Yang, Z. Varghese, J.F. Moorhead, Y. Chen, and X.Z. Ruan Inflammatory stress exacerbated mesangial foam cell formation and renal injury via disrupting cellular cholesterol homeostasis Inflammation 2014
28. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Investig. 108 8 2001 1167 1174
29. H. Zhu, C.M. Moriasi, M. Zhang, Y. Zhao, and M.H. Zou Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Czeta is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation J. Biol. Chem. 288 23 2013 16495 16505